Skip to main content
I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.923
-0.030 (-3.17%)
At close: Dec 20, 2024, 4:00 PM
0.953
+0.030 (3.27%)
After-hours: Dec 20, 2024, 6:26 PM EST

I-Mab Revenue

I-Mab had revenue of $3.31M in the twelve months ending September 30, 2024, down -118.30% year-over-year. In the year 2023, I-Mab had annual revenue of $27.64M, down -112.48%.

Revenue (ttm)
$3.31M
Revenue Growth
-118.30%
P/S Ratio
22.74
Revenue / Employee
$15,064
Employees
220
Market Cap
75.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.64M249.21M-112.48%
Dec 31, 2022-221.56M-309.59M-351.70%
Dec 31, 202188.03M-1.45B-94.29%
Dec 31, 20201.54B1.51B5,042.23%
Dec 31, 201930.00M-23.78M-44.22%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
23andMe Holding Co. 193.26M
Theratechnologies 84.32M
InspireMD 6.82M
Adlai Nortye 5.00M
Ikena Oncology 659.00K
Revenue Rankings

IMAB News

More News